{
  "content": "51C Lafuente-Lafuente, S Mouly, MA Long√°s-Tejero, et al. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials  Arch Intern Med, 166 (2006), pp. 719-728 10.1001/archinte.166.7.719 CrossrefGoogle Scholar \n52D Roy, M Talajic, P Dorian, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators  New Engl J Med, 342 (2000), pp. 913-920 View in ScopusGoogle Scholar",
  "source": "https://www.sciencedirect.com/science/article/pii/S1470211824021602",
  "chunk_id": "900766b6-774d-44b6-9e22-ce71ca8b744a",
  "similarity_score": 0.3693627119064331,
  "query": "atrial fibrillation recurrence rates maintenance therapy amiodarone beta-blockers long-term outcomes rhythm maintenance",
  "rank": 34,
  "title": "Advances in the management of atrial fibrillation",
  "authors": "Anthony Li, Elijah R Behr",
  "year": "2012",
  "journal": "Clinical Medicine",
  "reference": "Li, A., & Behr, E. R. (2012). Advances in the management of atrial fibrillation. Clinical Medicine, 12(6), 544-552. https://doi.org/10.7861/clinmedicine.12-6-544",
  "doi": "10.7861/clinmedicine.12-6-544",
  "chunk_index": 84,
  "total_chunks": 106,
  "retrieved_at": "2025-07-24T21:58:13.326325"
}